DIN 02436779 — ZYKADIA 150 MG
ZYKADIA is a capsule of Ceritinib marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Ceritinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02436779
- Brand name
- ZYKADIA
- Active ingredient
- Ceritinib
- Strength
- 150 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- ALK inhibitor (protein kinase inhibitor, antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.